# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615148 | A | Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase | Rattus norvegicus | 3 | assay format | Scientific Literature | ||
2. | ALA620997 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 100 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
3. | ALA620998 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 150 mg/kg | Mus musculus | 22 | organism-based format | Scientific Literature | ||
4. | ALA620999 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
5. | ALA621000 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
6. | ALA621001 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 225 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
7. | ALA621002 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 270 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA621003 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 275 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
9. | ALA621004 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg | Mus musculus | 114 | organism-based format | Scientific Literature | ||
10. | ALA621005 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (intraperitoneal dosing for 8 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
11. | ALA621006 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (ip dosing daily for 8 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
12. | ALA621007 | F | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 600 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
13. | ALA621008 | F | Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA621009 | F | Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA857705 | F | Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice | Mus musculus | 1 | organism-based format | Scientific Literature | ||
16. | ALA619828 | F | Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice | Mus musculus | 1 | organism-based format | Scientific Literature | ||
17. | ALA619829 | F | Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally | Mus musculus | 1 | organism-based format | Scientific Literature | ||
18. | ALA619830 | F | Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally | Mus musculus | 1 | organism-based format | Scientific Literature | ||
19. | ALA619831 | F | Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally | Mus musculus | 1 | organism-based format | Scientific Literature | ||
20. | ALA619832 | F | Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally | Mus musculus | 1 | organism-based format | Scientific Literature |